妇科肿瘤的特异性主动免疫治疗进展
摘要
肿瘤的特异性主动免疫治疗(SAIT),即用肿瘤疫苗刺激机体产生针对肿瘤特异性抗原的免疫反应,作为癌症患者手术、化疗或放疗的一种辅助治疗,目的是克服因肿瘤产物造成的免疫抑制状态,增强肿瘤相关抗原(TAA)的免疫原性,以刺激特异性免疫来攻击肿瘤细胞。肿瘤疫苗包括细胞疫苗。
出处
《国外医学（妇产科学分册）》
2003年第1期41-44,共4页
Foreign Medical Sciences(Obstet Gynecol Fascicle)
参考文献20
-
1Takashima I,Yamaguchi Y,Yorishima T,et al.Immunological properties of tumor cells genetically nodified to secrete interleukin-2.Anticncer Res,1999,19(6B):5299-5306
-
2Nomura T,Hasegawa H,Kohno M,et al.Enhancement of anti-tumor immunity by tumor transfected with the secondary lymphoid tissue chemokine EBI -1 -ligand chemokine and stromal cell-derived factor-lalpha chemokine genes.Int J Cancer,2001,91:597-606
-
3Lambright ES,Caparrelli DJ,Abbas AE,et al.Oncolytic therapy using a mutant type-1 herpes simplex virus and the role of the immune system.Ann Thorac Surg,1999,68:1756-1762
-
4Mobus V,Horn S,Stock M,et al.Tumor cell vaccination for gynecological tumors.Hybridoma,1993,12(5):543-547
-
5Hernando J J,Park TW,Kubler K,et al.Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies:clinical and immunological evaluation of a phase I trial.Cancer Immunol Immunother,2002,51(1):45-52
-
6Adams M,Borysiewicz L,Fiander A,et al.Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.Vaccine,2001,19:2549-2556
-
7Kaufmann AM,Nieland J,Schinz M,et al.HPV16 L1E7chimeric virus-like particles induce specific HLA-restricted T cells in humans after in vitro vaccination.
-
8Int J Cancer,2001,92(2):285-293Kim DK,Lee TV,Castilleja A,et al.Folate binding protein peptide 191-199 presented on dendritic cells can stimulate CTL from ovarian and breast cancer patients.Anticancer Res,1999,19:2907-2916
-
9Tendler A,Kaufman HL,Kadish AS.Increased carcinoembryonic antigen expression in cervical intraepithelial neoplasia grade 3 and in cervical squamous cell carcinoma.Hum Pathol,2000,31(11):1357-1362
-
10Wagner U,Kohler S,Reinartz S,et al.Immunological consolidation of ovarian carcinoma recurrences with monoclonal antibody ACA125:Immune responses and survival in palliative treatment.Clin Cancer Res,2001,1154(7):1154-1162
-
1杨琪玫(综述),谭获(审校).多发性骨髓瘤特异性主动免疫治疗研究新进展[J].国际输血及血液学杂志,2013,36(3):251-254.
-
2乔健.肿瘤特异性主动免疫治疗研究进展[J].国外医学（肿瘤学分册）,1994,21(3):155-157.
-
3张剑军（综述）,刘鲁明（审校）.胰腺癌免疫治疗进展[J].国际肿瘤学杂志,2007,34(1):58-61. 被引量：3
-
4何爱丽,赵万红.IL-2及/或GM-CSF在血液系统恶性肿瘤主动免疫治疗中的作用研究进展[J].国外医学（输血及血液学分册）,1999,22(3):174-176.
-
5娄彦艳,魏于全.肿瘤基因与分子疫苗的研究现状及进展[J].癌症,2000,19(1):90-91. 被引量：7
-
6罗锋.癌蛋白免疫原性及分子疫苗的研究进展[J].国外医学（肿瘤学分册）,1997,24(5):271-273.
-
7朱美,康德智.脑胶质瘤主动特异性免疫疗法新进展[J].医学综述,2007,13(9):685-688. 被引量：1
-
8葛宁灵,叶胜龙,刘银坤,郑宁,孙瑞霞,汤钊猷.白细胞介素-12基因再修饰基因瘤苗免疫小鼠的脾细胞过继治疗肝癌[J].中华实验外科杂志,2003,20(1):21-23. 被引量：2
-
9郑树法,康德智.胶质瘤主动特异性免疫治疗新进展[J].中华神经医学杂志,2005,4(2):206-209.
-
10韩霖,孙早喜.胰腺癌的树突状细胞治疗研究进展[J].中国热带医学,2008,8(2):317-318. 被引量：2
